drugset / Trial / NCT01804946

Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

NCT01804946

Phase 4 Completed 161 enrolled Materia Medica Holding
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is: * to assess clinical efficiency of Ergoferon for treatment of influenza * to assess safety of Ergoferon for treatment of influenza * to compare efficiency of Ergoferon and Tamiflu for treatment of influenza

Timeline

Start
2011-02
Primary completion
2014-04
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergoferon Protein / enzyme biologic 1 unknown
Comparator Oseltamivir Small molecule 75 mg

Indications